bpc 157 recommended dosage for regeneration BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Systemic Tissue Regeneration Drops BPC-157
Description
The structure allows researchers to do reproducible studies across different experimental conditions

Jour Clin Med Res

No cardiovascular signals

The BPC-157 cancer risk concern centers on its VEGFR2 upregulation
